Understanding the heterogeneous molecular landscape of prostate cancer is fundamental to improve treatment of the disease. Here, we aim to provide a broad molecular view of a cross- section of a prostate organ. This study manifests several unique tumor gene expression subtypes, with adjacent stroma, occupying distinct and different anatomical regions. The interplay between multiple molecularly defined tumor gene expression factors and/or Gleason scoring and the corresponding tumor microenvironment was hereby studied in detail. We perform a molecular sub-categorization of the tumor microenvironment throughout the whole prostate, using three different molecular principles; (i) AR staining, since loss of stromal AR is directly proportional to ...
Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized...
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterat...
Comprehensive genomic studies have delineated key driver mutations linked to disease progression for...
Understanding the heterogeneous molecular landscape of prostate cancer is fundamental to improve tre...
Understanding the heterogeneous molecular landscape of prostate cancer is fundamental to improve tre...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
The tumor microenvironment plays a crucial role in both the development and progression of prostate ...
The tumor microenvironment plays a crucial role in both the development and progression of prostate ...
The treatment of low-risk primary prostate cancer entails active surveillance only, while high-risk ...
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterat...
Prostate cancer affects millions of people worldwide. The current risk stratification and disease ma...
Background: Genomic analyses of hundreds of prostate tumors have defined a diverse ...
Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized...
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterat...
Comprehensive genomic studies have delineated key driver mutations linked to disease progression for...
Understanding the heterogeneous molecular landscape of prostate cancer is fundamental to improve tre...
Understanding the heterogeneous molecular landscape of prostate cancer is fundamental to improve tre...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
The tumor microenvironment plays a crucial role in both the development and progression of prostate ...
The tumor microenvironment plays a crucial role in both the development and progression of prostate ...
The treatment of low-risk primary prostate cancer entails active surveillance only, while high-risk ...
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterat...
Prostate cancer affects millions of people worldwide. The current risk stratification and disease ma...
Background: Genomic analyses of hundreds of prostate tumors have defined a diverse ...
Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized...
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterat...
Comprehensive genomic studies have delineated key driver mutations linked to disease progression for...